Terms: = Breast cancer AND TSHR, hTSHR-I, 7253, ENSG00000165409, MGC75129, LGR3 AND Treatment
5 results:
1. Targeting the inward rectifier potassium channel 5.1 in thyroid cancer: artificial intelligence-facilitated molecular docking for drug discovery.
Yang X; Wu Y; Xu S; Li H; Peng C; Cui X; Dhoomun DK; Wang G; Xu T; Dong M; Li X; Du Y
BMC Endocr Disord; 2023 May; 23(1):113. PubMed ID: 37208644
[TBL] [Abstract] [Full Text] [Related]
2. Long-term outcomes in corticosteroid-refractory Graves' orbitopathy treated with tocilizumab.
Moi L; Hamedani M; Ribi C
Clin Endocrinol (Oxf); 2022 Sep; 97(3):363-370. PubMed ID: 34908176
[TBL] [Abstract] [Full Text] [Related]
3. Hypothyroidism induces oxidative stress and DNA damage in breast.
Peixoto MS; de Vasconcelos E Souza A; Andrade IS; de Carvalho El Giusbi C; Coelho Faria C; Hecht F; Miranda-Alves L; Ferreira ACF; Carvalho DP; Fortunato RS
Endocr Relat Cancer; 2021 Jun; 28(7):505-519. PubMed ID: 34010147
[TBL] [Abstract] [Full Text] [Related]
4. Proto-oncogene PBF/PTTG1IP regulates thyroid cell growth and represses radioiodide treatment.
Read ML; Lewy GD; Fong JC; Sharma N; Seed RI; Smith VE; Gentilin E; Warfield A; Eggo MC; Knauf JA; Leadbeater WE; Watkinson JC; Franklyn JA; Boelaert K; McCabe CJ
Cancer Res; 2011 Oct; 71(19):6153-64. PubMed ID: 21844185
[TBL] [Abstract] [Full Text] [Related]
5. The dietary flavonoid apigenin blocks phorbol 12-myristate 13-acetate-induced COX-2 transcriptional activity in breast cell lines.
Yi Lau GT; Leung LK
Food Chem Toxicol; 2010 Oct; 48(10):3022-7. PubMed ID: 20691240
[TBL] [Abstract] [Full Text] [Related]
